Literature DB >> 8566844

Helicobacter pylori may induce bile reflux: link between H pylori and bile induced injury to gastric epithelium.

S D Ladas1, J Katsogridakis, H Malamou, H Giannopoulou, M Kesse-Elia, S A Raptis.   

Abstract

Helicobacter pylori and duodenogastric reflux are both recognised as playing aetiological roles in chronic gastritis. This study investigated whether H pylori colonisation of the antral mucosa and duodenogastric reflux are independent phenomena or have a causal relationship. Thirty eight patients (15 men, 23 women) aged (mean (SD)) 48 (17) years participated. Each patient underwent gastroscopy. Antral biopsy specimens were taken to investigate H pylori colonisation. In addition BrIDA-99mTc/111In-DTPA scintigraphy was used to quantify duodenogastric reflux. H pylori positive patients who were found to have duodenogastric reflux were treated with amoxycillin (1 g/d) and metronidazole (1.5 g/d) for seven days and four tablets of bismuth subcitrate daily for four weeks. Follow up antral biopsies and scintigraphy were repeated at six months. Duodenogastric reflux could not be found in 18 patients, including eight (44%) who were H pylori positive. Ten of the 11 patients who had duodenogastric reflux (reflux % 11.6 (9.2)), however, were H pylori positive (chi 2 = 6.26, p = 0.01). These 10 patients were given eradication treatment. At six months, in six patients who became H pylori negative, duodenogastric reflux was significantly reduced from a pretreatment value of 14.3% to 3.3% (two tail, paired t = 2.57, p = 0.016). These data suggest that H pylori may induced duodenogastric reflux which may be important in the pathogenesis of H pylori gastritis or carcinogenesis, or both.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566844      PMCID: PMC1382972          DOI: 10.1136/gut.38.1.15

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  Reversibility of pyloric sphincter dysfunction in gastric ulcer.

Authors:  R S Fisher; G Boden
Journal:  Gastroenterology       Date:  1975-09       Impact factor: 22.682

2.  Campylobacter pylori, acid, and bile.

Authors:  D S Tompkins; A P West
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

3.  Pyloric reflux and G-cell hyperfunction.

Authors:  J Calam; H J Tracy
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

4.  Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

Authors:  B J Marshall; J R Warren; G J Francis; S R Langton; C S Goodwin; E D Blincow
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

5.  Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.

Authors:  A Morris; G Nicholson
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

6.  Intragastric bile acids and histological changes in gastric mucosa.

Authors:  P W Houghton; N J Mortensen; W E Thomas; M J Cooper; A P Morgan; P Burton
Journal:  Br J Surg       Date:  1986-05       Impact factor: 6.939

7.  A simple method for the quantification of biliary reflux.

Authors:  J J Nicolai; J Silberbusch; F van Roon; W Schopman; J W vd Berg
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

8.  Reflux gastritis: distinct histopathological entity?

Authors:  M F Dixon; H J O'Connor; A T Axon; R F King; D Johnston
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

9.  Campylobacter like organisms and reflux gastritis.

Authors:  H J O'Connor; J I Wyatt; M F Dixon; A T Axon
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

10.  Lysolecithin: a factor in the pathogenesis of gastric ulceration?

Authors:  A G Johnson; S J McDermott
Journal:  Gut       Date:  1974-09       Impact factor: 23.059

View more
  15 in total

1.  Reproducibility and intragastric variation of duodenogastric reflux using ambulatory gastric bilirubin monitoring.

Authors:  D K Manifold; A Anggiansah; R E Marshall; W J Owen
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

Authors:  A B R Thomson; M Keelan; R Lastiwka; S Appelman-Eszczuk; L Zuk; L Drozdowski; A Prentice; P Sinclair
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

3.  Duodenogastric reflux following biliary reconstruction after excision of choledochal cyst.

Authors:  K Takada; Y Hamada; K Watanabe; A Tanano; K Tokuhara; Y Kamiyama
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

4.  Inhibiting acid and Helicobacter pylori?

Authors:  Z Healey; J Calam
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

5.  Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects.

Authors:  Masaru Nakamura; Ken Haruma; Tomoari Kamada; Mitsuhiro Mihara; Masaharu Yoshihara; Masaaki Sumioka; Toshiyuki Fukuhara; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

6.  Cell proliferation in type C gastritis affecting the intact stomach.

Authors:  J E Dowall; P Willis; R Prescott; S Lamonby; D A Lynch
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

7.  Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.

Authors:  D Gillen; A A Wirz; W D Neithercut; J E Ardill; K E McColl
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

8.  Gastric mucosa lesions induced by duodenogastric reflux increase penetration of N-[3H]-methyl-N-nitro-N-nitrosoguanidine into corpus mucosa of rats.

Authors:  Kjell K Ovrebø; Knut Svanes; Steinar Aase; Ketil Grong; Steinar Kvinnsland; Halfdan Sørbye
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

9.  Helicobacter pylori infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development.

Authors:  Andreea Szőke; Simona Mocan; Anca Negovan
Journal:  Exp Ther Med       Date:  2021-05-14       Impact factor: 2.447

Review 10.  Non-Acid Fluid Exposure and Esophageal Squamous Cell Carcinoma.

Authors:  Ali Soroush; Arash Etemadi; Julian A Abrams
Journal:  Dig Dis Sci       Date:  2021-07-08       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.